AFP and adenocarcinoma: This study evaluated thrombocyte counts and clotting parameters (INR, Prothrombin Activity, aPTT) in relation to tumour markers (CEA, CA19-9, CA125, AFP) within different histopathological groups (adenocarcinoma, benign lesions, metaplasia).